Q Qian1, X Li, X Huang, M Fu, Z Meng, M Chen, B Feng. 1. Department of Endocrinology and Metabolism, Shanghai East Hospital, Tongji University, 150 Ji-mo Rd., Shanghai 200120, China.
Abstract
BACKGROUND: Previous studies have shown that Type 2 diabetes mellitus (T2DM) is usually preceded by a condition known as pre-diabetes. However, few studies evaluate the rate of each status of impaired glucose regulation progressed to T2DM and its related metabolic disorders impacting the development. AIM: To investigate the natural outcome of glucose metabolism among Shanghai adult residents during a 5-yr period, and estimate the metabolic characteristics related with the conversion of glucose tolerance. SUBJECTS AND METHODS: A cross-sectional survey with multiple- stage and random sampling was conducted among 1869 adult residents from Shanghai Pudong New District in 2002. In 2007, 1042 non-diabetic subjects were successfully followed up. All the participants completed a questionnaire and underwent anthropometric measurements and a 75-g oral glucose tolerance test. RESULTS: The incidence of diabetes was higher in isolated impaired glucose tolerance (i- IGT), isolated impaired fasting glucose (i-IFG), and combined fasting and post-prandial hyperglycemia (IFG/IGT) group when compared to that in normal glucose tolerance group, as relative ratios with 95% confidence intervals of 9.2 (5.5- 15.2), 7.5 (3.6-15.7), and 13.2 (5.8-30.2), respectively. Subjects who had 2 or more metabolic disorders had a 2-3-fold higher incidence than those with less than 1 metabolic disorder (all p<0.001). CONCLUSIONS:People with pre-diabetes are at increased risk of diabetes, suggesting the need for frequent screening in theloe people with several metabolic disorders.
RCT Entities:
BACKGROUND: Previous studies have shown that Type 2 diabetes mellitus (T2DM) is usually preceded by a condition known as pre-diabetes. However, few studies evaluate the rate of each status of impaired glucose regulation progressed to T2DM and its related metabolic disorders impacting the development. AIM: To investigate the natural outcome of glucose metabolism among Shanghai adult residents during a 5-yr period, and estimate the metabolic characteristics related with the conversion of glucose tolerance. SUBJECTS AND METHODS: A cross-sectional survey with multiple- stage and random sampling was conducted among 1869 adult residents from Shanghai Pudong New District in 2002. In 2007, 1042 non-diabetic subjects were successfully followed up. All the participants completed a questionnaire and underwent anthropometric measurements and a 75-g oral glucose tolerance test. RESULTS: The incidence of diabetes was higher in isolated impaired glucose tolerance (i- IGT), isolated impaired fasting glucose (i-IFG), and combined fasting and post-prandial hyperglycemia (IFG/IGT) group when compared to that in normal glucose tolerance group, as relative ratios with 95% confidence intervals of 9.2 (5.5- 15.2), 7.5 (3.6-15.7), and 13.2 (5.8-30.2), respectively. Subjects who had 2 or more metabolic disorders had a 2-3-fold higher incidence than those with less than 1 metabolic disorder (all p<0.001). CONCLUSIONS:People with pre-diabetes are at increased risk of diabetes, suggesting the need for frequent screening in theloe people with several metabolic disorders.
Authors: Christian Meyer; Walkyria Pimenta; Hans J Woerle; Timon Van Haeften; Ervin Szoke; Asimina Mitrakou; John Gerich Journal: Diabetes Care Date: 2006-08 Impact factor: 19.112
Authors: B Paulweber; P Valensi; J Lindström; N M Lalic; C J Greaves; M McKee; K Kissimova-Skarbek; S Liatis; E Cosson; J Szendroedi; K E Sheppard; K Charlesworth; A-M Felton; M Hall; A Rissanen; J Tuomilehto; P E Schwarz; M Roden; M Paulweber; A Stadlmayr; L Kedenko; N Katsilambros; K Makrilakis; Z Kamenov; P Evans; A Gilis-Januszewska; K Lalic; A Jotic; P Djordevic; V Dimitrijevic-Sreckovic; U Hühmer; B Kulzer; S Puhl; Y H Lee-Barkey; A AlKerwi; C Abraham; W Hardeman; T Acosta; M Adler; A AlKerwi; N Barengo; R Barengo; J M Boavida; K Charlesworth; V Christov; B Claussen; X Cos; E Cosson; S Deceukelier; V Dimitrijevic-Sreckovic; P Djordjevic; P Evans; A-M Felton; M Fischer; R Gabriel-Sanchez; A Gilis-Januszewska; M Goldfracht; J L Gomez; C J Greaves; M Hall; U Handke; H Hauner; J Herbst; N Hermanns; L Herrebrugh; C Huber; U Hühmer; J Huttunen; A Jotic; Z Kamenov; S Karadeniz; N Katsilambros; M Khalangot; K Kissimova-Skarbek; D Köhler; V Kopp; P Kronsbein; B Kulzer; D Kyne-Grzebalski; K Lalic; N Lalic; R Landgraf; Y H Lee-Barkey; S Liatis; J Lindström; K Makrilakis; C McIntosh; M McKee; A C Mesquita; D Misina; F Muylle; A Neumann; A C Paiva; P Pajunen; B Paulweber; M Peltonen; L Perrenoud; A Pfeiffer; A Pölönen; S Puhl; F Raposo; T Reinehr; A Rissanen; C Robinson; M Roden; U Rothe; T Saaristo; J Scholl; P E Schwarz; K E Sheppard; S Spiers; T Stemper; B Stratmann; J Szendroedi; Z Szybinski; T Tankova; V Telle-Hjellset; G Terry; D Tolks; F Toti; J Tuomilehto; A Undeutsch; C Valadas; P Valensi; D Velickiene; P Vermunt; R Weiss; J Wens; T Yilmaz Journal: Horm Metab Res Date: 2010-04-13 Impact factor: 2.936
Authors: X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard Journal: Diabetes Care Date: 1997-04 Impact factor: 19.112